Standout Papers
Citation Impact
Citing Papers
Loss of independence in early Parkinson disease
2016
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
2011 Standout
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
2010 StandoutScienceNobel
Gating the Selectivity Filter in ClC Chloride Channels
2003 StandoutScienceNobel
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
2018
Hypoxia-inducible factors regulate human and rat cystathionine β-synthase gene expression
2013 StandoutNobel
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease
2019
Efficacy and Safety of Deep Brain Stimulation in the Treatment of Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
2018
Cognitive training for freezing of gait in Parkinson’s disease: a randomized controlled trial
2018
Comprehensive Examination of Therapies for Pain in Parkinson’s Disease: A Systematic Review and Meta-Analysis
2018
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Recurrent inhibitory circuitry as a mechanism for grid formation
2013 StandoutNobel
Patient-centered integrated healthcare improves quality of life in Parkinson’s disease patients: a randomized controlled trial
2018
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018
Parkinson's disease
2021 Standout
Hypothalamic regulation of sleep and circadian rhythms
2005 StandoutNature
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Descending control of pain
2002 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Risk and course of motor complications in a population-based incident Parkinson's disease cohort
2015
Foxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c
2016 StandoutNobel
Neurexins Physically and Functionally Interact with GABAA Receptors
2010 StandoutNobel
Differential Regulation of Action Potential Shape and Burst-Frequency Firing by BK and Kv2 Channels in Substantia Nigra Dopaminergic Neurons
2015
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
2008
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
2002 StandoutNature
Enzyme-inhibitor-like tuning of Ca2+ channel connectivity with calmodulin
2010 Nature
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
2010 Standout
Gender effect on non-motor symptoms in Parkinson's disease: are men more at risk?
2016
Dopaminergic modulation of motor network dynamics in Parkinson's disease
2015
A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology
2008 Standout
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation
2012
Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids
2002
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
Information Coding in the Vertebrate Olfactory System
1996 StandoutNobel
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data
2017
Autophagy: Renovation of Cells and Tissues
2011 Standout
Timing and Location of Synaptic Inputs Determine Modes of Subthreshold Integration in Striatal Medium Spiny Neurons
2007
Mitochondria: In Sickness and in Health
2012 Standout
What causes cell death in Parkinson's disease?
2009
MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons
2010
Frequency of gamma oscillations routes flow of information in the hippocampus
2009 StandoutNatureNobel
GABAA Receptor Downregulation in Brains of Subjects with Autism
2008
Excitatory GABA Action Is Essential for Morphological Maturation of Cortical NeuronsIn Vivo
2007
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Cleft lip and palate
2009 Standout
Altered receptor subtypes in the forebrain of GABAA receptor δ subunit-deficient mice: recruitment of γ2 subunits
2002
Late-stage Parkinson disease
2012
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
2018
TWO SPECIES OF GAMMA OSCILLATIONS IN THE OLFACTORY BULB: DEPENDENCE ON BEHAVIORAL STATE AND SYNAPTIC INTERACTIONS
2003
Parkinson's disease
2015 Standout
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
2014
Drug repurposing: progress, challenges and recommendations
2018 Standout
Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat
2000
Molecular control of secondary palate development
2006
Corticostriatal and Thalamostriatal Synapses Have Distinctive Properties
2008
Mechanisms of mitophagy
2010 Standout
Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: A prospective trial
2019
Calmodulin Suppresses Synaptotagmin-2 Transcription in Cortical Neurons*
2010 StandoutNobel
Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
2011 Standout
Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior
2010 StandoutNobel
Mouse models of autism spectrum disorders: The challenge for behavioral genetics
2006
Anesthesia Sensitivity in Mice that Lack the β3 Subunit of the γ-Aminobutyric Acid Type A Receptor
1998
A review of central 5-HT receptors and their function
1999 Standout
Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function
2000
Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
2018
SWELL1, a Plasma Membrane Protein, Is an Essential Component of Volume-Regulated Anion Channel
2014 StandoutNobel
Inositol trisphosphate and calcium signalling
1993 StandoutNature
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
Murine CASK Is Disrupted in a Sex-Linked Cleft Palate Mouse Mutant
1998
The nature of sites of general anaesthetic action
2002
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial
2020
Deep-Brain Stimulation for Parkinson's Disease
2012
Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study
2017
Physiological Phenotype and Vulnerability in Parkinson's Disease
2012
Disynaptic Inhibition between Neocortical Pyramidal Cells Mediated by Martinotti Cells
2007
Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease
2014
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
2015 StandoutNature
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
2011
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
2017
Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
2009 StandoutNobel
Knockouts model the 100 best-selling drugs—will they model the next 100?
2002
Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
2009
Structure and function of inositol triphosphate receptors
1991
Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities
2018
The Movement Disorder Society Nonmotor Rating Scale: Initial Validation Study
2019
The neurexin ligands, neuroligins and leucine-rich repeat transmembrane proteins, perform convergent and divergent synaptic functions in vivo
2011 StandoutNobel
Characterization of a novel inositol 1,4,5-trisphosphate receptor in isolated olfactory cilia
1992
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
1995 Standout
Higher Seizure Susceptibility and Enhanced Tyrosine Phosphorylation of N-Methyl-d-Aspartate Receptor Subunit 2B in fyn Transgenic Mice
1998 StandoutNobel
Diagnosis and Treatment of Parkinson Disease
2020 Standout
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
2011
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
2014
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
Deletion of CASK in mice is lethal and impairs synaptic function
2007 StandoutNobel
Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease
2012
Hydrogel bioelectronics
2018 Standout
NMDA/AMPA Ratio Impacts State Transitions and Entrainment to Oscillations in a Computational Model of the Nucleus Accumbens Medium Spiny Projection Neuron
2005
Molecular Structure and Physiological Function of Chloride Channels
2002
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents
2000
Insertional Mutagenesis by a Hybrid PiggyBac and Sleeping Beauty Transposon in the Rat
2012
Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)
2018
Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease
2019
Evidence for a Common Binding Cavity for Three General Anesthetics within the GABAAReceptor
2001
Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease
2017
General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA A receptor β3 subunit
2002
Magnetic Resonance Imaging–Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease
2019
The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
2020 Standout
Nonreciprocal homeostatic compensation in Drosophila potassium channel mutants
2017 StandoutNobel
TheCaenorhabditis elegansGeneunc-25Encodes Glutamic Acid Decarboxylase and Is Required for Synaptic Transmission But Not Synaptic Development
1999 StandoutNobel
CASK Participates in Alternative Tripartite Complexes in which Mint 1 Competes for Binding with Caskin 1, a Novel CASK-Binding Protein
2002 StandoutNobel
Physiology of Microglia
2011 Standout
Analysis of GABAA Receptor Function and Dissection of the Pharmacology of Benzodiazepines and General Anesthetics Through Mouse Genetics
2004
Cleft palate in mice with a targeted mutation in the γ-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67
1997 StandoutNobel
Works of Caroline Rick being referenced
Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
2010
Two sulphonated dye compounds which compete for inositol 1,4,5-trisphosphate binding to rat liver microsomes: Effects on 5′-phosphatase activity
1990
A cluster randomised feasibility trial evaluating nutritional interventions in the treatment of malnutrition in care home adult residents
2015
Comparing results from long and short form versions of the Parkinson's disease questionnaire in a longitudinal study
2015
Spontaneous Voltage Oscillations in Striatal Projection Neurons in a Rat Corticostriatal Slice
2003
Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the γ2 subunit of the γ-aminobutyrate type A receptor
1999
Propofol and Other Intravenous Anesthetics Have Sites of Action on the γ-Aminobutyric Acid Type A Receptor Distinct from That for Isoflurane
1998
Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptaminein vitro: Evidence for a direct action mediated by 5-hydroxytryptamine2C receptors
1995
Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial
2017
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
2007 Nature
Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease
2016
Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB)
2016
Mice devoid of γ-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior
1997